Howard Bradley Schiller, EVP and CFO at Valeant Pharmaceuticals International, Inc. (VRX), bought 32,500 shares at $46.05 ($1.5M) on 2011-12-01, disclosed to the SEC on 2011-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.05 | 21,500 | $990K | 66.1% |
| 2 | $46.26 | 11,000 | $509K | 33.9% |
| Total | $46.12 avg | 32,500 | $1.5M | 100% |
| Filing → |
| VRX | BUY | 2012-03-05 | $998K | — | Filing → |
| VRX | BUY | 2011-12-09 | $501K | — | Filing → |
| VRX | BUY | 2011-12-07 | $515K | — | Filing → |